FIELD: medicine.
SUBSTANCE: presented group of inventions refers to medicine, namely to medical diagnostics. Disclosed is a method and kit for assessing the therapeutic benefit of remote management of a patient with heart failure, comprising comparing the level of at least one biomarker selected from a group, consisting of medium-regional proadrenomedullin (CP-proADM), N-terminal natriuretic propeptide B-type (NT-proBNP) and/or medium-regional natriuretic propeptide A-type (CP-proPNP) with one or more reference values, wherein said level of at least one biomarker indicates appropriateness of prescribing or not prescribing remote control for said patient.
EFFECT: presented group of inventions provides therapeutic benefit of remote management of a patient with heart failure by determining the level of CP-proADM, NT-proBNP and/or CP-proPNP in the sample.
16 cl, 15 dwg, 20 tbl, 3 ex
| Title |
Year |
Author |
Number |
| PROADRENOMEDULLIN AS MARKER INDICATING UNFAVORABLE EVENT |
2018 |
- Wilson, Darius Cameron
- Bermejo, Jesus
- Andaluz, David
- Calvo, Dolores
|
RU2775090C2 |
| PROADM FOR PREDICTING RISK OF CONDITION REQUIRING HOSPITALIZATION IN PATIENTS WITH SYMPTOMS OF INFECTIOUS DISEASE |
2019 |
- Vilson, Darius
- Bermekho Martin, Khesus Fransisko
- Garsiya Ortis, Luis
- Errero Rodriges, Karmen
|
RU2820944C2 |
| ANTIBODY AGAINST ADRENOMEDULLIN (ADM), OR FRAGMENT OF ANTI-ADM ANTIBODY, OR ANTI-ADM NON-IG FRAME FOR USE IN INTERVENTION AND THERAPY OF HYPEREMIA IN PATIENT |
2017 |
|
RU2762059C2 |
| THERAPY MONITORING IN TREATMENT WITH BINDING AGENT AGAINST ADRENOMEDULLIN (ADM) |
2018 |
- Struck, Joachim
- Bergmann, Andreas
|
RU2776811C2 |
| DETERMINING HGH FOR USE IN PREVENTING A SEVERE ADVERSE CARDIOVASCULAR EVENT OR CARDIOVASCULAR DISEASE IN AN INDIVIDUAL |
2015 |
- Bergmann, Andreas
- Melander, Olle
- Ng, Leong
|
RU2740254C2 |
| METHODS FOR DETERMINING DPP3 AND THERAPEUTIC METHODS |
2017 |
|
RU2771824C2 |
| METHODS OF DIAGNOSING STROKE, EFFECTIVENESS OF THERAPY, AND DETERMINING RISK OF STROKE |
2019 |
- Timsit, Serge
- Genin, Emmanuelle
|
RU2821748C2 |
| METHODS OF TREATING TTP WITH IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS AND THEIR USE |
2015 |
|
RU2807602C2 |
| THERAPEUTIC TARGETED FUSION PROTEINS BASED ON LYSOSOMAL ENZYMES, RELEVANT COMPOSITIONS AND THEIR APPLICATIONS |
2017 |
- Moshashaee Saeed
- Pinkstaff Jason K.
- Shaywitz Adam
- Ciaccio Natalie
|
RU2751235C2 |
| EXO-SOMATIC BIOMARKERS |
2015 |
- Lozupone Francesco
- Chiesi Antonio
- Guazzi Paolo
- Zarovni Natasa
- Ferruzzi Pietro
- Zocco Davide
|
RU2712223C2 |
